228 related articles for article (PubMed ID: 32428972)
1. A real-world experience with the bioactive human split thickness skin allograft for venous leg ulcers.
Kirsner RS; Margolis D; Masturzo A; Bakewell K
Wound Repair Regen; 2020 Jul; 28(4):547-552. PubMed ID: 32428972
[TBL] [Abstract][Full Text] [Related]
2. Human Skin Allograft for Patients With Diabetic Foot Ulcers, Venous Leg Ulcers, or Surgical/Traumatic Wounds Retrospective, Descriptive Study.
Desman E; Bartow W; Anderson LH
Ostomy Wound Manage; 2015 Jul; 61(7):16-22. PubMed ID: 26185972
[TBL] [Abstract][Full Text] [Related]
3. VIEW-VLU observational study of the effect of Varithena on wound healing in the treatment of venous leg ulcers.
Shao MY; Harlin S; Chan B; Santangelo K; Fukaya E; Stoughton J; Kolluri R;
J Vasc Surg Venous Lymphat Disord; 2023 Jul; 11(4):692-699.e1. PubMed ID: 36972751
[TBL] [Abstract][Full Text] [Related]
4. AVURT: aspirin versus placebo for the treatment of venous leg ulcers - a Phase II pilot randomised controlled trial.
Tilbrook H; Clark L; Cook L; Bland M; Buckley H; Chetter I; Dumville J; Fenner C; Forsythe R; Gabe R; Harding K; Layton A; Lindsay E; McDaid C; Moffatt C; Rolfe D; Sbizzera I; Stansby G; Torgerson D; Vowden P; Williams L; Hinchliffe R
Health Technol Assess; 2018 Oct; 22(55):1-138. PubMed ID: 30325305
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of an electroceutical device in treating non-healing venous leg ulcers: results of an RCT.
Guest JF; Singh H; Rana K; Vowden P
J Wound Care; 2018 Apr; 27(4):230-243. PubMed ID: 29637824
[TBL] [Abstract][Full Text] [Related]
6. Clinical and cost efficacy of advanced wound care matrices for venous ulcers.
Hankin CS; Knispel J; Lopes M; Bronstone A; Maus E
J Manag Care Pharm; 2012 Jun; 18(5):375-84. PubMed ID: 22663170
[TBL] [Abstract][Full Text] [Related]
7. The Wound Healing Index for Predicting Venous Leg Ulcer Outcome.
Fife CE; Horn SD
Adv Wound Care (New Rochelle); 2020 Feb; 9(2):68-77. PubMed ID: 31903300
[No Abstract] [Full Text] [Related]
8. A cost-effectiveness analysis of a hydration response technology dressing in the treatment of venous leg ulcers in the UK.
Walzer S; Dröschel D; Vollmer L; Atkin L; Ousey K
J Wound Care; 2018 Mar; 27(3):166-172. PubMed ID: 29509113
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of venous leg ulcers in primary health care: Incidence and prevalence in a health centre-A time series study (2010-2014).
Berenguer Pérez M; López-Casanova P; Sarabia Lavín R; González de la Torre H; Verdú-Soriano J
Int Wound J; 2019 Feb; 16(1):256-265. PubMed ID: 30393963
[TBL] [Abstract][Full Text] [Related]
10. Economic benefit of a novel dual-mode ambulatory compression device for treatment of chronic venous leg ulcers in a randomized clinical trial.
Marston WA; Kirsner RS; Tallis A; Hanft JR; Walters J; Farber A;
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1031-1040.e1. PubMed ID: 32451241
[TBL] [Abstract][Full Text] [Related]
11. Relative cost-effectiveness of a skin protectant in managing venous leg ulcers in the UK.
Guest JF; Taylor RR; Vowden K; Vowden P
J Wound Care; 2012 Aug; 21(8):389-94, 396-8. PubMed ID: 22885312
[TBL] [Abstract][Full Text] [Related]
12. Venous leg ulcer management in clinical practice in the UK: costs and outcomes.
Guest JF; Fuller GW; Vowden P
Int Wound J; 2018 Feb; 15(1):29-37. PubMed ID: 29243398
[TBL] [Abstract][Full Text] [Related]
13. Wool-derived keratin dressings versus usual care dressings for treatment of slow-healing venous leg ulceration: study protocol for a randomised controlled trial (Keratin4VLU).
Jull A; Wadham A; Bullen C; Parag V; Waters J
BMJ Open; 2018 Feb; 8(2):e020319. PubMed ID: 29440219
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors associated with healing of venous leg ulcers: a multicentre, prospective, cohort study.
Chaby G; Senet P; Ganry O; Caudron A; Thuillier D; Debure C; Meaume S; Truchetet F; Combemale P; Skowron F; Joly P; Lok C;
Br J Dermatol; 2013 Nov; 169(5):1106-13. PubMed ID: 23909381
[TBL] [Abstract][Full Text] [Related]
15. A single-arm trial indirect comparison investigation: a proof-of-concept method to predict venous leg ulcer healing time for a new acellular synthetic matrix matched to standard care control.
Shannon R; Nelson A
Int Wound J; 2017 Aug; 14(4):729-741. PubMed ID: 27868341
[TBL] [Abstract][Full Text] [Related]
16. Treatment patterns and outcomes of Medicare enrolees who developed venous leg ulcers.
Tettelbach WH; Driver V; Oropallo A; Kelso MR; Niezgoda JA; Wahab N; De Jong JL; Hubbs B; Forsyth RA; Magee GA
J Wound Care; 2023 Nov; 32(11):704-718. PubMed ID: 37907359
[TBL] [Abstract][Full Text] [Related]
17. Biomodulation induced by fluorescent light energy versus standard of care in venous leg ulcers: a retrospective study.
Dini V; Janowska A; Davini G; Kerihuel JC; Fauverghe S; Romanelli M
J Wound Care; 2019 Nov; 28(11):730-736. PubMed ID: 31721664
[TBL] [Abstract][Full Text] [Related]
18. Treatment of superficial and perforator reflux and deep venous stenosis improves healing of chronic venous leg ulcers.
Lawrence PF; Hager ES; Harlander-Locke MP; Pace N; Jayaraj A; Yohann A; Kalbaugh C; Marston W; Kabnick L; Saqib N; Pouliot S; Piccolo C; Kiguchi M; Peralta S; Motaganahalli R
J Vasc Surg Venous Lymphat Disord; 2020 Jul; 8(4):601-609. PubMed ID: 32089497
[TBL] [Abstract][Full Text] [Related]
19. A retrospective clinical study of 188 consecutive patients to examine the effectiveness of a biologically active cryopreserved human skin allograft (TheraSkin®) on the treatment of diabetic foot ulcers and venous leg ulcers.
Landsman AS; Cook J; Cook E; Landsman AR; Garrett P; Yoon J; Kirkwood A; Desman E
Foot Ankle Spec; 2011 Feb; 4(1):29-41. PubMed ID: 21135263
[TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with the venous leg ulcer that fails to heal after 1 year of treatment.
Melikian R; O'Donnell TF; Suarez L; Iafrati MD
J Vasc Surg Venous Lymphat Disord; 2019 Jan; 7(1):98-105. PubMed ID: 30558732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
